In this sense, we reported an enhanced expression of hepatic OLFM2 mRNA in moderate and severe stages of steatosis in comparison to those subjects without steatosis (Figure 2A); while we did not find significant differences when OLFM4 was analysed, as graphically represented in Figure 2B. This evidence concerns the gene OLFM4 and steatosis.